nytimes June 22, 2021 4:00am Many Alzheimer’s Experts Say Use of Aduhelm Should Be Sharply Limited #yourfeedscience #alzheimersdisease #aduhelmdrug #drugspharmaceuticals #labelingandlabelsproduct #clinicaltrials #alzheimersassn #biogeninc #foodanddrugadministration #yourfeedhealthcare #news Many Alzheimer’s Experts Say Use of Aduhelm Should Be Sharply Limited Even those who supported the F.D.A.’s approval of the controversial new drug said authorizing it for anyone with Alzheimer’s disease was much too broad.
There are no comments yet.